AzTrials
AzTrials

Hernia, InguinalNCT05420818

Inversion and Fixation of the Transversalis Fascia in Laparoscopic Inguinal Hernia Repair

A study testing Transversalis Fascia Inversion in people with Hernia, Inguinal, run by Istanbul Training and Research Hospital at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

According to the EHS classification, at least 80 patients who will undergo TEP repair for the first time with the diagnosis of M2 and M3 direct inguinal hernia will be randomized into 2 groups. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Hernia, Inguinal
What is being tested?
Transversalis Fascia Inversion
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteTurkey (Türkiye)
Study dates
5 May 2022to 5 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Clinical or/and radiological diagnosis of primary inguinal hernia
  • EHS type M2 and M3 direct hernias
  • Laparoscopic totally extraperitoneal (TEP) repair

Who cannot join

  • Indirect hernias
  • M1 direct hernias
  • Recurrent hernias
  • Patients with previous groin operations on same side
  • Pregnant women
  • Patients who did not accept to participate in the study
  • ASA score of 3 or higher,

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site, 1 recruiting
  • Istanbul Research and Training Hospital

    Istanbul, Fatih, 34098

    Erol Aydın, MD, +905322546001, erolay@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Does Inversion and Fixation of the Transversalis Fascia Prevent Postoperative Seroma Formation in Patients Undergoing Laparoscopic Inguinal Hernia Repair?

According to the EHS classification, at least 80 patients who will undergo TEP repair for the first time with the diagnosis of M2 and M3 direct inguinal hernia will be randomized into 2 groups. After direct hernia reduction in the patients in the first group, the transversalis fascia at the hernia site will be pulled inward and fixed to the Cooper ligament with 2 or 3 absorbable tackers. Standard surgery will then be continued. The patients in the second group will undergo standard surgery without any seroma prevention procedure. Demographic data, clinical/radiological seroma rate, postoperative pain (VAS values),quality of life(SF36 questionnaire), recurrence and other complications at postoperative 1st, 7th day, 3rd and 6th month will be monitored. When the desired number of patients and the follow-up period are reached, the data in the 2 groups will be compared.

Being tested
Transversalis Fascia Inversion
Keywords
Inguinal Hernia, TEP, Seroma, Laparoscopic Hernia, Transversalis fascia inversion
Medical subject headings
Hernia, Inguinal, Seroma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transversalis Fascia InversionProcedure or surgery

    Also called TEP

    This study will be carried out at SBU Istanbul Training and Research Hospital, General Surgery Clinic. Patients diagnosed with M2 and M3 direct primary inguinal hernia according to EHS classification and who will undergo TEP repair surgery will be randomized into 2 groups. After direct hernia reduction in the patients in the first group, the transversalis fascia at the hernia site will be pulled inward and fixed to the Cooper ligament with 2 or 3 absorbable tackers. Standard surgery will then be continued. The patients in the second group will undergo standard surgery without any seroma prevention procedure. Demographic data of patients in both groups, postoperative pain (VAS values) at postoperative 1st, 7th day and 3rd month, clinical/radiological seroma rate, postoperative pain, QOL, recurrence and other complications will be recorded. When the desired number of patients and follow-up period are reached, the data in the 2 groups will be compared.

Study groups in NCT05420818
Study groupRoleWhat they receive
Active GroupExperimentalPatients who underwent transversalis fascia inversion during TEP
Receives: Procedure: Transversalis Fascia Inversion
Control GroupNo interventionPatients who did not undergo transversalis fascia inversion during TEP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Seroma formation rate

    The clinical/radiological seroma formation rates between the groups with and without transversalis fascia inversion and fixation.

    Measured: 3 month

Secondary outcomes (3)
  1. Chronic pain and quality of life measures

    Detect the presence of chronic pain and measuring quality of life after 3 months using the SF-36

    Measured: 3 month

  2. Pain levels

    Pain Scores on the Visual Analog Scale at postoperative 7tht day

    Measured: 7 day

  3. Postoperative pain levels

    Pain Scores on the Visual Analog Scale at postoperative 1st day

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jun 2022
  2. Study start5 May 2022
  3. Primary completion5 May 2023 (estimated)
  4. Study completion5 Jul 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05420818
Sponsor's protocol ID
2983
Status last verified
Jul 2022
First submitted
13 May 2022
Last updated
21 Jul 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Transversalis Fascia Inversion in people with Hernia, Inguinal, run by Istanbul Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Seroma formation rate (time frame: 3 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in